A Simple Step to Close a Dangerous Biosecurity Gap
NTI President and CEO Christine E. Wormuth joins fellow leaders in calling on U.S. policymakers to act with urgency and establish clear national standards for DNA synthesis screening.
Risky Business
Welcome to the blog
Here we highlight the work of NTI and share knowledge, ideas, and viewpoints addressing the crosscutting challenges our world faces—addressing risks while supporting innovation—to make our world safer.
Three Strikes: Why Giving Up on the NPT Is Not an Option
AIxBio Horizon Scan Finds Accelerating Capabilities Require Urgent Oversight
The Legacy of Ted Turner: “We all have a stake.”
What Would Make a New Iran Deal Better than the Last One?
Stay Informed
Sign up for our newsletter to get the latest on nuclear and biological threats.
Why the World Must Reject New Nuclear Tests
Some former government officials are proposing that the United States resume explosive nuclear weapons testing. It is exactly the wrong response to today’s escalating nuclear threats.
Risky Business is edited by:
Scott Nolan Smith
Senior Director, Communications
Mary Olney Fulham
Director, Communications